From: Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer
Variable |  | Responders (n = 39) | Non-responders (n = 11) |  |
---|---|---|---|---|
n or mean (std) | n or mean (std) | p value | ||
Age | Years | 58.5 (7.6) | 61.7 (9.9) | 0.26 |
Gender | Male | 32 | 8 | 0.49 |
Female | 7 | 3 | Â | |
Clinical stage | 0/1 | - | - | 0.34 |
2 | 1 | 1 | Â | |
3 | 3 | 2 | Â | |
4 | 35 | 8 | Â | |
T stage | T1 | 5 | 1 | 0.95 |
T2 | 11 | 4 | Â | |
T3 | 9 | 2 | Â | |
T4 | 13 | 4 | Â | |
X | 1 | - | Â | |
N stage | N0 | 3 | 3 | 0.31 |
N1 | 3 | 1 | Â | |
N2 | 31 | 7 | Â | |
N3 | 2 | - | Â | |
Disease site | Larynx | 7 | 3 | 0.21 |
Oral cavity | - | 1 | Â | |
Oropharynx | 31 | 7 | Â | |
Unknown primary | 1 | - | Â | |
ACE comorbidities Score | None | 12 | 3 | 0.79 |
Mild | 20 | 5 | Â | |
Moderate | 6 | 2 | Â | |
Severe | 1 | 1 | Â | |
BMI | Normal (15.5–24.9) | 7 | 4 | 0.34 |
Overweight (25–29.9) | 18 | 5 |  | |
Obese (30 +) | 14 | 2 |  | |
HPV status | Negative | 7 | 6 | 0.04 |
Positive | 29 | 4 | Â | |
Unknown | 3 | 1 | Â | |
Drinker | Never | - | 1 | 0.16 |
Current | 28 | 7 | Â | |
Former (quit > 12 months) | 11 | 3 |  | |
Smoker (cigarettes) | Never | 11 | - | 0.14 |
Current | 16 | 6 | Â | |
Former (quit > 12 months) | 12 | 5 |  |